Pharmion pharmion.com


Public list: Smart Money VCs (6328) Pharma Startups (4743) Cancer Therapeutics (1148)

Pharmion is a specialty pharmaceutical company focused on licensing, developing and commercializing therapeutic products for the treatment of hematology and oncology patients. Approved products include Vidaza for myelodysplastic syndromes and Thalidomide for multiple myeloma.

Pharmion is a specialty pharmaceutical company focused on licensing, developing and commercializing therapeutic products for the treatment of hematology and oncology patients. Approved products include Vidaza for myelodysplastic syndromes and Thalido...Show all

Company (Acquired)

Phone: 720-564-9100

Fax:

2525 28th Street
Suite 200
Boulder, 80301
Colorado, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Pharmion $153.5M Mar 10, 2008

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Pharmion Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Domain AssociatesVenture CapitalPrinceton, New Jersey, United StatesSeries B, Series A
Aberdare VenturesVenture CapitalSan Francisco, California, United StatesSeries B, Series A
Bay City CapitalVenture CapitalSan Francisco, California, United StatesSeries C, Series B
General ElectricCorporationBoston, Massachusetts, United StatesSeries C
AbingworthVenture CapitalLondon, England, United KingdomSeries B, Series A
See all 16 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Synthesis of 5-azacytidine Mar 29, 2012 Apr 24, 2018 Patent
Pharmaceutical compositions comprising 5-azacytidine monohydrate May 25, 2010 Jul 15, 2014 Patent